Psyence Biomedical Ltd.
PBM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.24M in total; no superinvestor holds it.
Other share classesPBMWW
Q2 2025 vs. Q1 2025
How the institutions holding Psyence Biomedical Ltd. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 8 | 6 | −2 |
| Shares | 455.0K | 305.6K | −149.4K (−32.8%) |
| Value | $272.8K | $625.3K | +$352.4K (+129.2%) |
New holders (2)
Institutions that held Psyence Biomedical Ltd. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parallel Advisors, LLC | 275,000 | $462.0K | 0.01% |
| Bank of America Corp | 3,340 | $17.8K | 0.00% |
Sold out (4)
Institutions that held Psyence Biomedical Ltd. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 75,318 | $45.2K |
| Virtu Financial LLC | 36,482 | $22.0K |
| Two Sigma Securities, LLC | 12,941 | $7.76K |
| Morgan Stanley | 69 | $41 |